Journal of Clinical Pharmacy and Therapeutics

Cover image for Vol. 30 Issue 2

April 2005

Volume 30, Issue 2

Pages 97–192

  1. Editorial

    1. Top of page
    2. Editorial
    3. Commentary
    4. Original Articles
    5. Pharmacogenetics
    6. Case Report
    7. Erratum
  2. Commentary

    1. Top of page
    2. Editorial
    3. Commentary
    4. Original Articles
    5. Pharmacogenetics
    6. Case Report
    7. Erratum
    1. You have free access to this content
  3. Original Articles

    1. Top of page
    2. Editorial
    3. Commentary
    4. Original Articles
    5. Pharmacogenetics
    6. Case Report
    7. Erratum
    1. Long-term tolerability of tramadol LP, a new once-daily formulation, in patients with osteoarthritis or low back pain (pages 113–120)

      H. Malonne, M. Coffiner, D. Fontaine, B. Sonet, A. Sereno, A. Peretz and F. Vanderbist

      Version of Record online: 14 MAR 2005 | DOI: 10.1111/j.1365-2710.2004.00624.x

    2. Dose-finding study of ibuprofen in patent ductus arteriosus using the continual reassessment method (pages 121–132)

      L. Desfrere, S. Zohar, P. Morville, A. Brunhes, S. Chevret, G. Pons, G. Moriette, E. Rey and J. M. Treluyer

      Version of Record online: 14 MAR 2005 | DOI: 10.1111/j.1365-2710.2005.00630.x

    3. Comparison of mirtazapine and fluoxetine in the treatment of major depressive disorder: a double-blind, randomized trial (pages 133–138)

      H. Amini, S. Aghayan, S. A. Jalili, S. Akhondzadeh, O. Yahyazadeh and M. Pakravan-Nejad

      Version of Record online: 14 MAR 2005 | DOI: 10.1111/j.1365-2710.2004.00585.x

    4. Comparison of the effect of aminophylline and low PEEP vs. high PEEP on EGF concentration in critically ill patients with ALI/ARDS (pages 139–144)

      P. Salari, M. Mojtahedzadeh, A. Najafi, S. Sadraie, K. Bahaadini, M. Moharreri, N. Hadavand and M. Abdollahi

      Version of Record online: 14 MAR 2005 | DOI: 10.1111/j.1365-2710.2004.00621.x

    5. Adoption of celecoxib and rofecoxib: a nationwide database study (pages 145–152)

      A. Helin-Salmivaara, R. Huupponen, A. Virtanen and T. Klaukka

      Version of Record online: 14 MAR 2005 | DOI: 10.1111/j.1365-2710.2005.00627.x

    6. Grapefruit juice–nifedipine interaction: possible involvement of several mechanisms (pages 153–158)

      P. Odou, N. Ferrari, C. Barthélémy, S. Brique, M. Lhermitte, A. Vincent, C. Libersa and H. Robert

      Version of Record online: 14 MAR 2005 | DOI: 10.1111/j.1365-2710.2004.00618.x

  4. Pharmacogenetics

    1. Top of page
    2. Editorial
    3. Commentary
    4. Original Articles
    5. Pharmacogenetics
    6. Case Report
    7. Erratum
    1. A study of the in vitro interaction between lidocaine and premedications using human liver microsomes (pages 185–188)

      A. Nagashima, E. Tanaka, S. Inomata, K. Honda and S. Misawa

      Version of Record online: 14 MAR 2005 | DOI: 10.1111/j.1365-2710.2004.00617.x

  5. Case Report

    1. Top of page
    2. Editorial
    3. Commentary
    4. Original Articles
    5. Pharmacogenetics
    6. Case Report
    7. Erratum
    1. Clearance rates of cerivastatin metabolites in a patient with cerivastatin-induced rhabdomyolysis (pages 189–192)

      H. Ozaki, C. T. Ishikawa, T. Ishii, A. Toyoda, T. Murano, Y. Miyashita and K. Shirai

      Version of Record online: 14 MAR 2005 | DOI: 10.1111/j.1365-2710.2005.00633_1.x

  6. Erratum

    1. Top of page
    2. Editorial
    3. Commentary
    4. Original Articles
    5. Pharmacogenetics
    6. Case Report
    7. Erratum
    1. You have free access to this content
      Erratum (page 192)

      Version of Record online: 14 MAR 2005 | DOI: 10.1111/j.1365-2710.2005.00633_2.x

SEARCH

SEARCH BY CITATION